MAT2A is a synthetic lethal target in cancers with genomic deletion of methylthioadenosine phosphorylase (MTAP)21–24, and was shown to be a metabolic vulnerability of tumour-initiating cells in lung cancer21–25. The gene discussed is MTAP; the disease is neoplasm.